Athira Pharma Inc (NAS:ATHA)
$ 0.5102 0.0198 (4.04%) Market Cap: 19.60 Mil Enterprise Value: -71.51 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 42/100

Athira Pharma Inc Annual Shareholders Meeting Transcript

May 18, 2023 / 03:00PM GMT
Release Date Price: $2.84 (+2.90%)
Operator

Welcome to the annual meeting for Athira Pharma, Inc. Our host for today's call is Mark Litton. At this time, all participants will be in a listen-only mode. I will now turn the call over to your host. Mark Litton, you may begin.

Mark Litton
Athira Pharma, Inc. - President, CEO

Good morning. I am Mark Litton, President, CEO, and member of the Board of Directors of Athira Pharma. Welcome to our annual 2023 meeting.

I would like to introduce Kelly Romano, Chairperson of the Board of Directors, who will call the meeting to order and serve as the Chairperson of this meeting.

Kelly Romano
Athira Pharma, Inc. - Chairwoman of the Board

Thanks, Mark, and good morning to everyone. I now call the meeting to order. With us here today are the following members of our Board of Directors; Mark Litton, Joseph Edelman, John Fluke Jr., James Johnson, Barbara Kosacz, Michael Panzara, Grant Pickering and myself, Kelly Romano.

In addition to Dr. Litton, we have with us here today, other senior management of Athira

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot